Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,777 across all filing types
Latest filing 2016-05-24 Governance Information
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
股东大会工作条例（2016年修订）
Governance Information Classification · 95% confidence The document is titled as the "Shareholders' Meeting Work Rules" of a company, detailing the procedures, powers, and regulations governing the company's shareholders' meetings. It includes chapters on the general provisions, convening of meetings, proposals and notifications, meeting conduct, voting, resolutions, and amendments to the rules. The content is procedural and regulatory in nature, focusing on the governance and operation of shareholder meetings rather than reporting financial results or announcements. It does not contain financial statements, earnings data, or voting results from a specific meeting. Instead, it outlines the internal rules and governance practices related to shareholder meetings. Therefore, this document fits best under the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2016-05-24 Chinese
关于子公司取得新兽药注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by 金宇生物技术股份有限公司 regarding its subsidiary obtaining new veterinary drug registration certificates. It details the new products, their registration numbers, development background, and expected market impact. The document is relatively short (2096 characters) and serves as an official announcement of a regulatory approval event rather than a financial report or detailed management discussion. There are no financial statements, earnings data, or detailed management analysis. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not a voting result or board change announcement. The content is regulatory in nature, announcing a certificate approval by a government body (Agriculture Ministry). Therefore, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2016-05-24 Chinese
新任高级管理人员简历
Board/Management Information Classification · 100% confidence The document contains detailed biographies of newly appointed senior management personnel of the company, including their educational background, work experience, and current roles. There is no financial data, regulatory references, or report announcements. The content clearly relates to management changes and appointments.
2016-05-20 Chinese
股权激励计划首次授予限制性股票第二期解锁及预留限制性股票第一次解锁暨上市公告
Share Issue/Capital Change Classification · 95% confidence The document is a detailed announcement regarding the unlocking and listing of restricted shares under a stock incentive plan by the company 金宇生物技术股份有限公司. It includes specifics about the stock unlocking schedule, conditions met for unlocking, legal opinions, and changes in share capital structure. The content focuses on the implementation and progress of a stock incentive plan, which is a capital change event related to share issuance and unlocking of restricted shares. There is no indication that this is a full financial report, audit report, or earnings release. It is not a simple announcement of a report publication but a substantive disclosure about share capital changes and stock unlocking. Therefore, the document fits best under the category of Share Issue/Capital Change (SHA).
2016-05-20 Chinese
独立董事关于聘任公司高级管理人员的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion regarding the appointment of senior management personnel at a company. It references compliance with company law and governance rules, and discusses qualifications and appointment procedures for senior executives. There is no financial data, no mention of financial results, no regulatory filings or voting results, and no indication of a report publication. The content is focused on management appointments, which fits the category of Board/Management Information (MANG). The document length is short and it is a formal opinion on management appointments, not a full report or announcement of voting results.
2016-05-20 Chinese
关于选举第九届监事会职工监事的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of a new employee supervisor to the company's ninth supervisory board. It includes details about the election process and the biography of the elected individual. There is no financial data, no mention of financial results, reports, or regulatory certifications. The content focuses on board/management changes specifically related to the supervisory board. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not a report publication announcement or certification. Hence, the classification is MANG with high confidence.
2016-05-19 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.